References
- Haas S, Schiff I. Symptoms of oestrogen deficiency. In Studd JWW, Whitehead MI, eds. The Menopause. Oxford, UK: Blackwell Scientific Publications, 1988:15–23
- Hextall A, Cardozo L. The effect of estrogen deficiency on the bladder. In Studd J, ed. The Management of the Menopause. Annual Review 1998. Carnforth, UK: Parthenon Publishing, 1998:39–47
- Eriksen EF, Kassem M. The clinical problem of treating osteoporosis with estrogens. In Studd J, ed. The Management of the Menopause. Annual Review 1998. Carnforth, UK: Parthenon Publishing 1998: 121–34
- Grodstein F, Stampfer MJ. The cardioprotective effects of estrogens. In Studd J, ed. The Management of the Menopause. Annual Review 1998. Carnforth, UK: Parthenon Publishing, 1998:211–19
- Philibert D, Bouchoux F, Degryse M, Lecaque D, Petit F, Gaillard M. The pharmacological profile of a novel no rpregnane progestin (trimegestone). Gynecol Endocrinol 1999;13:316–26
- Lepescheux L, Secchi J, Gaillard-Kelly M, Miller P. Effects of 1713-estradiol and trimegestone alone, and in combination, on the bone and uterus of ovari-ectomized rats. Gynecol Endocrinol 2001;15: 312–20
- Ross D, Godfree V, Cooper A, Pryse-Davies J, Whitehead MI. Endometrial effects of three doses of trimegestone, a new orally active progestogen, on the postmenopausal endometrium. Maturitas 1997; 28:83–8
- Al-Azzawi F, Wahab M, Thompson J, Pornel B, Hirvonen E, Ylikorkala 0, van der Mooren MJ, Dillon J. Acceptability and patterns of endometrial bleeding in estradiol-based HRT regimens: a com-parative study of cyclical sequential combinations of trimegestone or norethisterone acetate. Climacteric 2001;4:in press
- Kupperman HS, Blatt MGH, Weisbader H, Filler W. Comparative clinical evaluation of estrogenic preparations by the menopausal and amenorrheal indices. J Clin Endocrinol Metab 1953;13:688–703